Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles

A series of new morpholinylchalcones was prepared and then used as building blocks for constructing a series of 7-morpholino-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones via their reaction with 6-aminothiouracil. The latter thiones reacted with the appropriate hydrazonoyl chloride to give t...

Full description

Bibliographic Details
Main Authors: Zeinab A. Muhammad, Mastoura M. Edrees, Rasha A. M. Faty, Sobhi M. Gomha, Seham S. Alterary, Yahia N. Mabkhot
Format: Article
Language:English
Published: MDPI AG 2017-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/7/1211
_version_ 1819170471544881152
author Zeinab A. Muhammad
Mastoura M. Edrees
Rasha A. M. Faty
Sobhi M. Gomha
Seham S. Alterary
Yahia N. Mabkhot
author_facet Zeinab A. Muhammad
Mastoura M. Edrees
Rasha A. M. Faty
Sobhi M. Gomha
Seham S. Alterary
Yahia N. Mabkhot
author_sort Zeinab A. Muhammad
collection DOAJ
description A series of new morpholinylchalcones was prepared and then used as building blocks for constructing a series of 7-morpholino-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones via their reaction with 6-aminothiouracil. The latter thiones reacted with the appropriate hydrazonoyl chloride to give the corresponding pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones. The assigned structures for all the newly synthesized compounds were confirmed on the basis of elemental analyses and spectral data and the mechanisms of their formation were also discussed. Most of the synthesized compounds were tested for in vitro activity against human lung cancer (A-549) and human hepatocellular carcinoma (HepG-2) cell lines compared with the employed standard antitumor drug (cisplatin) and the results revealed that compounds 8, 4e and 7b have promising activities against the A-549 cell line (IC50 values of 2.78 ± 0.86 μg/mL, 5.37 ± 0.95 μg/mL and 5.70 ± 0.91 μg/mL, respectively) while compound 7b has promising activity against the HepG-2 cell lines (IC50 = 3.54 ± 1.11 μg/mL). Moreover, computational studies using MOE 2014.09 software supported the biological activity results.
first_indexed 2024-12-22T19:35:55Z
format Article
id doaj.art-338a433166c44227a95b33885ddb34d9
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-22T19:35:55Z
publishDate 2017-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-338a433166c44227a95b33885ddb34d92022-12-21T18:14:58ZengMDPI AGMolecules1420-30492017-07-01227121110.3390/molecules22071211molecules22071211Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based HeterocyclesZeinab A. Muhammad0Mastoura M. Edrees1Rasha A. M. Faty2Sobhi M. Gomha3Seham S. Alterary4Yahia N. Mabkhot5Department of Organic Chemistry, National Organization for Drug Control and Research (NODCAR), Giza 12311, EgyptDepartment of Organic Chemistry, National Organization for Drug Control and Research (NODCAR), Giza 12311, EgyptDepartment of Chemistry, Faculty of Science, Cairo University, Giza 12613, EgyptDepartment of Chemistry, Faculty of Science, Cairo University, Giza 12613, EgyptDepartment of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi ArabiaDepartment of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi ArabiaA series of new morpholinylchalcones was prepared and then used as building blocks for constructing a series of 7-morpholino-2-thioxo-2,3-dihydropyrido[2,3-d]pyrimidin-4(1H)-ones via their reaction with 6-aminothiouracil. The latter thiones reacted with the appropriate hydrazonoyl chloride to give the corresponding pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones. The assigned structures for all the newly synthesized compounds were confirmed on the basis of elemental analyses and spectral data and the mechanisms of their formation were also discussed. Most of the synthesized compounds were tested for in vitro activity against human lung cancer (A-549) and human hepatocellular carcinoma (HepG-2) cell lines compared with the employed standard antitumor drug (cisplatin) and the results revealed that compounds 8, 4e and 7b have promising activities against the A-549 cell line (IC50 values of 2.78 ± 0.86 μg/mL, 5.37 ± 0.95 μg/mL and 5.70 ± 0.91 μg/mL, respectively) while compound 7b has promising activity against the HepG-2 cell lines (IC50 = 3.54 ± 1.11 μg/mL). Moreover, computational studies using MOE 2014.09 software supported the biological activity results.https://www.mdpi.com/1420-3049/22/7/1211morpholinechalconesthioneshydrazonoyl halidesanticancer activitymolecular docking
spellingShingle Zeinab A. Muhammad
Mastoura M. Edrees
Rasha A. M. Faty
Sobhi M. Gomha
Seham S. Alterary
Yahia N. Mabkhot
Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
Molecules
morpholine
chalcones
thiones
hydrazonoyl halides
anticancer activity
molecular docking
title Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_full Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_fullStr Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_full_unstemmed Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_short Synthesis, Antitumor Evaluation and Molecular Docking of New Morpholine Based Heterocycles
title_sort synthesis antitumor evaluation and molecular docking of new morpholine based heterocycles
topic morpholine
chalcones
thiones
hydrazonoyl halides
anticancer activity
molecular docking
url https://www.mdpi.com/1420-3049/22/7/1211
work_keys_str_mv AT zeinabamuhammad synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT mastouramedrees synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT rashaamfaty synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT sobhimgomha synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT sehamsalterary synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles
AT yahianmabkhot synthesisantitumorevaluationandmoleculardockingofnewmorpholinebasedheterocycles